Although these cell lines are both derived from cutaneous melanoma bearing BRAFV600E mutation, they are known to have different genetic statuses regarding PTEN, P53, CDKN2A, and CDK4 as reported by Villanueva and colleagues [43]. This evidence concerns the gene TP53 and cutaneous melanoma.